Owner and operator of a biotechnology company intended to identify and therapeutically exploit mechanisms of cancer cell resistance. The company's proteomics platform, metadata analysis and predictive analytics develops new targeted therapies to treat various diseases such as pancreatic cancer, acquired resistance metastatic melanoma and others, enabling doctors to make the deadly cancers survivable.